Mostaxyl (Rupatadine)

Rupatadine works by selectively blocking peripheral histamine H1 receptors, preventing histamine‑induced allergic responses, and by antagonizing platelet‑activating factor (PAF) receptors, which reduces the release of inflammatory mediators and further alleviates allergy symptoms.

The appropriate dose of Mostaxyl is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of symptoms, and overall health status. Patients should follow the exact regimen provided by their prescriber.

Safety data for rupatadine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Mostaxyl.

To request Mostaxyl, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with first‑generation antihistamines, rupatadine (Mostaxyl) offers effective H1‑receptor blockade with a lower incidence of sedation. It also uniquely blocks the platelet‑activating factor (PAF) receptor, providing additional anti‑inflammatory benefits not seen with many other second‑generation antihistamines.

Mostaxyl should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight, and excessive heat to maintain product stability.

Mostaxyl is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions given by their prescriber to ensure optimal absorption and effect.

Serious adverse reactions, although rare, include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience swelling of the face or throat, rash, or signs of liver dysfunction.

Mostaxyl is contraindicated in individuals with known hypersensitivity to rupatadine or any of the tablet’s excipients. Caution is also advised for patients with severe hepatic impairment, as safety has not been established in this population.